Literature DB >> 32673142

'If the results are negative, they motivate us'. Experiences of early infant diagnosis of HIV and engagement in Option B.

David Etoori1, Jenny Renju1,2, Georges Reniers1,3, Violet Ndhlovu3, Sherly Ndubane3, Princess Makhubela3, Meriam Maritze3, Francesc Xavier Gomez-Olive3, Alison Wringe1.   

Abstract

Few studies have explored the relationship between early infant diagnosis (EID) of HIV and mothers' engagement in care under Option B+. We conducted in-depth interviews with 20 women who initiated antiretroviral therapy (ART) under Option B+ in rural South Africa to explore the interactions between EID and maternal care engagement. Drawing on practice theory, we identified themes relating to Option B+ care engagement and EID. Women's practice of engagement with HIV care shaped their decision-making around EID. Mothers who disengaged from care during pregnancy were less inclined to utilise EID as they lacked information about its availability and benefits. For some mothers, tensions between wanting to breastfeed and perceptions that it could facilitate transmission led to repeated utilisation of EID as reassurance that the child remained negative. Some mothers used their child's negative result as a proxy for their status, subsequently disengaging from care. For some participants, an HIV diagnosis of their infant and the subsequent double burden of treatment visits for themselves and their infant, contributed to their disengagement. Women's care-seeking practices for themselves and their infants work in a symbiotic ecosystem and should be viewed interdependently to tailor interventions to improve EID uptake and Option B+ care engagement.

Entities:  

Keywords:  EID; HIV; PMTCT; engagement; retention

Year:  2020        PMID: 32673142     DOI: 10.1080/17441692.2020.1795220

Source DB:  PubMed          Journal:  Glob Public Health        ISSN: 1744-1692


  1 in total

1.  Do Women Enrolled in PMTCT Understand the Recommendations: A Case Study from Kilimanjaro.

Authors:  Rune N Philemon; Blandina T Mmbaga; John Bartlett; Jenny Renju; Tara Mtuy; Innocent B Mboya; Sia E Msuya
Journal:  Patient Prefer Adherence       Date:  2021-06-16       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.